Price
Target price
€0.005
€0.005
-
-
-
-
30.04.24 / Frankfurt
WKN: A2P7XA / Name: Nova Mentis Life Science / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Nova Mentis Life Science Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Nova Mentis Life Science Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Nova Mentis Life Science Corp. | - | 0.000% | 0.000% | -84.375% | 900.000% | -92.424% | -98.698% |
| NeutriSci International Inc | - | 0.000% | 0.000% | -66.667% | 0.000% | -98.745% | -96.725% |
| Avricore Health Inc. | 19.390% | -3.509% | 5.769% | -54.670% | -25.676% | -45.364% | 210.150% |
| AEterna Zentaris Inc. | -2.190% | -1.081% | -9.406% | -36.348% | 4.811% | -91.663% | -97.962% |
News
Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group
Vancouver, British Columbia - November 03, 2023 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader
